Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation.

This research article investigates how certain medications, specifically unfractionated and low-molecular-weight heparin, as well as phosphodiesterase inhibitors IBMX and Cilostazol, can inhibit platelet activation induced by equid herpesvirus type-1.

Introduction

• The study is essentially a corrigendum, i.e., a correction to a previous article published, addressing the impacts of certain medications on platelet activation initiated by equid herpesvirus type-1.
• Equid herpesvirus type-1 is a pathogen causing infection in horses, and it leads to severe neurological disorders. A key part of the infection process is the activation of platelets, the cells responsible for blood clotting.
• This platelet activation exacerbates symptoms, so identifying ways to inhibit this activation is key.

Medications Investigated

• The article primarily focuses on the effects of specific medications: unfractionated heparin, low-molecular-weight heparin, and phosphodiesterase inhibitors (including IBMX and Cilostazol).
• Heparins are anticoagulant medications, i.e., they prevent blood clots from forming hence, potentially preventing the virus-triggered platelet activation.
• Phosphodiesterase inhibitors like IBMX and Cilostazol are drugs used to prevent or decrease the effects of certain diseases like chronic obstructive pulmonary disease, and they do so by blocking the action of phosphodiesterase enzymes to increase the concentration of beneficial metabolites in the body.

Findings

• The study found that these medications can block the platelet activation caused by equid herpesvirus type-1. This provides a potential pharmacological treatment for illnesses caused by the virus in horses.
• However, as this is a correction to a previous research, it might include amendments or refinements to the methodologies, results or conclusions previously drawn.